Search Results - "KAWABATA, Atsufumi"
-
1
Prostaglandin E2 and Pain—An Update
Published in Biological & Pharmaceutical Bulletin (2011)“…Prostaglandin E2 (PGE2), a cyclooxygenase (COX) product, is the best known lipid mediator that contributes to inflammatory pain. Nonsteroidal anti-inflammatory…”
Get full text
Journal Article -
2
Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy
Published in International journal of molecular sciences (31-12-2020)“…Chemotherapy-induced peripheral neuropathy (CIPN), one of major dose-limiting side effects of first-line chemotherapeutic agents such as paclitaxel,…”
Get full text
Journal Article -
3
Role of high‐mobility group box 1 and its modulation by thrombomodulin/thrombin axis in neuropathic and inflammatory pain
Published in British journal of pharmacology (01-02-2021)“…High‐mobility group box 1 (HMGB1), a nuclear protein, once released to the extracellular space, facilitates pain signals as well as inflammation. Intraplantar…”
Get full text
Journal Article -
4
Macrophage as a Peripheral Pain Regulator
Published in Cells (Basel, Switzerland) (24-07-2021)“…A neuroimmune crosstalk is involved in somatic and visceral pathological pain including inflammatory and neuropathic components. Apart from microglia essential…”
Get full text
Journal Article -
5
Dietary Zinc Deficiency Induces Cav3.2-Dependent Nociceptive Hypersensitivity in Mice
Published in Biological & pharmaceutical bulletin (01-09-2023)“…Cav3.2 channels belong to the T-type calcium channel (T-channel) family, i.e., low voltage-activated calcium channels, and are abundantly expressed in the…”
Get full text
Journal Article -
6
Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan
Published in PloS one (31-12-2021)“…Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse reaction in cancer patients treated with several cytotoxic anticancer agents…”
Get full text
Journal Article -
7
T-type Calcium Channels: Functional Regulation and Implication in Pain Signaling
Published in Journal of Pharmacological Sciences (2013)“…Low-voltage-activated T-type Ca2+ channels (T-channels), especially Cav3.2 among the three isoforms (Cav3.1, Cav3.2, and Cav3.3), are now considered to play…”
Get full text
Journal Article -
8
Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk
Published in Neuropharmacology (01-10-2018)“…Given our recent evidence for the role of high mobility group box 1 (HMGB1) in chemotherapy-induced peripheral neuropathy (CIPN) in rats, we examined the…”
Get full text
Journal Article -
9
Development of diabetes mellitus following hormone therapy in prostate cancer patients is associated with early progression to castration resistance
Published in Scientific reports (25-08-2021)“…To identify risk factors for the prognosis of prostate cancer (PC), we retrospectively analyzed the impact of lifestyle-related disorders as well as PC…”
Get full text
Journal Article -
10
Involvement of Voltage-Gated Calcium Channels in Inflammation and Inflammatory Pain
Published in Biological & pharmaceutical bulletin (01-08-2018)“…Voltage-gated calcium channels (VGCCs) are classified into high-voltage-activated (HVA) channels and low-voltage-activated channels consisting of Cav3.1–3.3,…”
Get full text
Journal Article -
11
Endogenous Hydrogen Sulfide Enhances Cell Proliferation of Human Gastric Cancer AGS Cells
Published in Biological & pharmaceutical bulletin (01-05-2016)“…Hydrogen sulfide (H2S), the third gasotransmitter, is endogenously generated by certain H2S synthesizing enzymes, including cystathionine-γ-lyase (CSE) and…”
Get full text
Journal Article -
12
Effects of Bepridil and Pimozide, Existing Medicines Capable of Blocking T-Type Ca2+ Channels, on Visceral Pain in Mice
Published in Biological & pharmaceutical bulletin (01-03-2021)“…T-Type Ca2+ channels (T-channels), particularly Cav3.2, are now considered as therapeutic targets for treatment of intractable pain including visceral pain…”
Get full text
Journal Article -
13
Characterization of Potentially Inappropriate Medications That Need Special Attention in the Elderly with Dementia by Analyzing Pharmacy Claims Data
Published in Biological & pharmaceutical bulletin (01-12-2023)“…Community pharmacists may play a key role in promoting deprescribing of potential inappropriate medications (PIMs) that are highly prevalent among…”
Get full text
Journal Article -
14
Opposing impact of hypertension/diabetes following hormone therapy initiation and preexisting statins on castration resistant progression of nonmetastatic prostate cancer: a multicenter study
Published in Scientific reports (04-10-2024)“…Hormone therapy, especially androgen deprivation therapy (ADT), is effective against prostate cancer (PC), whereas long-term ADT is a risk for…”
Get full text
Journal Article -
15
Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical study
Published in Journal of pharmacological sciences (01-05-2021)“…We performed clinical retrospective study in female cancer patients and fundamental experiments in mice, in order to clarify risk factors for…”
Get full text
Journal Article -
16
H2S and Pain: A Novel Aspect for Processing of Somatic, Visceral and Neuropathic Pain Signals
Published in Handbook of experimental pharmacology (2015)“…Hydrogen sulfide (H2S) formed by multiple enzymes including cystathionine-γ-lyase (CSE) targets Cav3.2 T-type Ca2+ channels (T-channels) and transient receptor…”
Get more information
Journal Article -
17
A Combination of Cryopreservation and Kneading Maintains the Usability of Mohs Paste
Published in Chemical & pharmaceutical bulletin (01-06-2020)“…Mohs paste is useful for controlling exudates from wounds and infections and is used to treat patients with inoperable skin tumors. Unfortunately, Mohs paste…”
Get full text
Journal Article -
18
Changes in Percutaneous Absorption of Fentanyl Patches in Rats Treated with a Sebum-Like Secretion
Published in Chemical & pharmaceutical bulletin (01-09-2020)“…The percutaneous absorption of a fentanyl (FEN)-patch is affected by various external factors including the volume of sebum secretion, which causes changes in…”
Get full text
Journal Article -
19
Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants
Published in Journal of neuroinflammation (30-10-2019)“…Macrophage-derived high mobility group box 1 (HMGB1), a damage-associated molecular pattern (DAMP) protein, plays a key role in the development of…”
Get full text
Journal Article -
20
Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy
Published in Scientific reports (10-01-2024)“…Given possible involvement of the central and peripheral angiotensin system in pain processing, we conducted clinical and preclinical studies to test whether…”
Get full text
Journal Article